Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine for SUI/MUI in elderly women
NCT00244296Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 7
01
Overview
Phase 4, randomised, double-blind trial in stress urinary incontinence (SUI) and mixed urinary incontinence (MUI) comparing Duloxetine with Placebo (2 arms). Primary endpoint: Efficacy of duloxetine compared to placebo in treating symptoms of pure stress urinary incontinence (SUI) or stress-predominant mixed urinary incontinence at 12 weeks. Started Oct 2005; status: completed.
02
Drugs
duloxetine
03
Conditions
stress urinary incontinence (SUI)mixed urinary incontinence (MUI)
Beyond the preview
Go deeper on NCT00244296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00244296.